Followers | 3817 |
Posts | 147046 |
Boards Moderated | 4 |
Alias Born | 08/05/2009 |

Wednesday, April 06, 2022 11:23:00 AM
amazing how these things work
#RobotTrading
Always consult an Investment Professional, my posts are my own
opinions, and not for investing decisions
Liked By
Spread the love. Be the first to like this post!
Recent ACHL News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/22/2023 08:42:59 PM
- Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement • GlobeNewswire Inc. • 09/22/2023 08:30:00 PM
- Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation • InvestorsHub NewsWire • 09/20/2023 12:45:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/17/2023 07:16:47 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/04/2023 11:42:07 AM
- Achilles Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights • GlobeNewswire Inc. • 08/04/2023 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/29/2023 08:03:49 PM
- Achilles Therapeutics to Present at Upcoming Conferences • GlobeNewswire Inc. • 06/12/2023 12:00:00 PM
- Achilles Therapeutics Reports First Quarter 2023 Financial Results and Recent Business Highlights • GlobeNewswire Inc. • 05/10/2023 11:15:00 AM
- Achilles Therapeutics’ New Immunogenicity Prediction Application of its AI-Powered PELEUS™ Platform Uniquely Identifies the Most Potent T Cell Antigens • GlobeNewswire Inc. • 05/10/2023 11:00:00 AM
- Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement • GlobeNewswire Inc. • 04/25/2023 10:00:00 PM
- Achilles Therapeutics Announces Grant of US Patent Covering the Treatment of Patients with an Immunotherapy Targeting Neoantigens Based on Tumor HLA Status • GlobeNewswire Inc. • 04/25/2023 11:00:00 AM
- Achilles Therapeutics to Present at Chardan’s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit • GlobeNewswire Inc. • 04/17/2023 12:00:00 PM
- Chardan Capital Keeps Their Buy Rating on Achilles Therapeutics (ACHL) • TipRanks • 11/09/2022 12:38:13 PM
Green Egg to launch $150 million bond offer for quicklime products production kiln plant Sep 22, 2023 12:11 PM
Nate's Food Co. Announces Reverse Merger and Change of Control with JP Energy Group to Drive Global Expansion • NHMD • Sep 22, 2023 9:00 AM
Trio Petroleum Corp Provides Update on Testing of the HV-1 Discovery Well • TPET • Sep 21, 2023 9:38 AM
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation • GNPX • Sep 20, 2023 8:45 AM
Caduceus Provides Update on Its Plans for The Second Half of The Fiscal Year • CSOC • Sep 20, 2023 8:26 AM
RESILIENT ENERGY INC. (RENI) PURSUING ACQUISITION TARGETS • RENI • Sep 19, 2023 10:30 AM